Elite Pharmaceuticals (ELTP) Current Deferred Revenue (2011 - 2025)
Elite Pharmaceuticals' Current Deferred Revenue came in at $2,222 for fiscal Q1 2026 (quarter ended Jun 30, 2025), down 83.3% from $13,333 a year earlier and down 60.0% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Current Deferred Revenue (2011 - 2025) Analysis & Trends
At the end of FY2025 (ended Mar 31, 2025), Elite Pharmaceuticals' Current Deferred Revenue was $5,556, down 58.3% from FY2024.
- Current Deferred Revenue carries a five-year compound annual growth rate of -50.1% (FY2020 to FY2025).
- Going back by fiscal year, Current Deferred Revenue was $13,333 in FY2024 (unchanged), $13,333 in FY2023 (unchanged), $13,333 in FY2022 (unchanged) and $13,333 in FY2021 (-92.6%).
- The fiscal Q1 2026 figure represents the lowest quarterly Current Deferred Revenue in data going back to fiscal Q4 2011.
- Year-over-year, Current Deferred Revenue has declined for four consecutive quarters, with an average decline of 22.9% over the last eight quarters.
- Across the past five years, year-over-year decline in Current Deferred Revenue ran from 0.0% in fiscal Q1 2025 to 98.0% in fiscal Q2 2021.
- Business Quant data shows ELTP's Current Deferred Revenue at $5,556 (Q4 2025), $8,889 (Q3 2025) and $12,222 (Q2 2025) in the three fiscal quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 2,222.00 |
| Mar 31, 2025 | 5,556.00 |
| Dec 31, 2024 | 8,889.00 |
| Sep 30, 2024 | 12,222.00 |
| Jun 30, 2024 | 13,333.00 |
| Mar 31, 2024 | 13,333.00 |
| Dec 31, 2023 | 13,333.00 |
| Sep 30, 2023 | 13,333.00 |
| Jun 30, 2023 | 13,333.00 |
| Mar 31, 2023 | 13,333.00 |
| Dec 31, 2022 | 13,333.00 |
| Sep 30, 2022 | 13,333.00 |
| Mar 31, 2022 | 13,333.00 |
| Dec 31, 2021 | 13,333.00 |
| Sep 30, 2021 | 13,333.00 |
| Jun 30, 2021 | 13,333.00 |
| Mar 31, 2021 | 13,333.00 |
| Dec 31, 2020 | 13,333.00 |
| Sep 30, 2020 | 13,333.00 |
| Jun 30, 2020 | 13,333.00 |
API Access
Elite Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();